WallStreetZenWallStreetZen

NASDAQ: ATAI
Atai Life Sciences Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ATAI

Based on 2 analysts offering 12 month price targets for Atai Life Sciences Nv

Min Forecast
$10.00+261.01%
Avg Forecast
$11.00+297.11%
Max Forecast
$12.00+333.21%

Should I buy or sell ATAI stock?

Based on 2 analysts offering ratings for Atai Life Sciences Nv.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ATAI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ATAI as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ATAI stock forecasts and price targets.

ATAI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-02
lockedlocked$00.00+00.00%2025-05-20

1 of 1

Forecast return on equity

Is ATAI forecast to generate an efficient return?

Company
-44.14%
Industry
165.03%
Market
89.46%
ATAI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ATAI forecast to generate an efficient return on assets?

Company
-34.28%
Industry
43.47%
ATAI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ATAI earnings per share forecast

What is ATAI's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.54
Avg 2 year Forecast
-$0.62
Avg 3 year Forecast
-$0.46

ATAI revenue forecast

What is ATAI's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$2.4M+26.14%
Avg 2 year Forecast
$1.5M-19.48%
Avg 3 year Forecast
$5.1M+173.75%
ATAI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ATAI revenue growth forecast

How is ATAI forecast to perform vs Biotechnology companies and vs the US market?

Company
32.06%
Industry
55.22%
Market
10.26%
ATAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ATAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ATAI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATAI$2.77$11.00+297.11%Strong Buy
TBPH$11.15$21.33+91.33%Strong Buy
AMLX$6.30$12.60+100.00%Strong Buy
KROS$13.45$20.63+53.35%Buy
MNMD$7.17$28.50+297.49%Strong Buy
View Top Biotech Stocks

Atai Life Sciences Nv Stock Forecast FAQ

Is Atai Life Sciences Nv Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ATAI) stock is to Strong Buy ATAI stock.

Out of 2 analysts, 1 (50%) are recommending ATAI as a Strong Buy, 1 (50%) are recommending ATAI as a Buy, 0 (0%) are recommending ATAI as a Hold, 0 (0%) are recommending ATAI as a Sell, and 0 (0%) are recommending ATAI as a Strong Sell.

If you're new to stock investing, here's how to buy Atai Life Sciences Nv stock.

What is ATAI's earnings growth forecast for 2025-2027?

(NASDAQ: ATAI) Atai Life Sciences Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.78%.

Atai Life Sciences Nv's earnings in 2025 is -$148,987,000.On average, 4 Wall Street analysts forecast ATAI's earnings for 2025 to be -$108,683,153, with the lowest ATAI earnings forecast at -$144,243,078, and the highest ATAI earnings forecast at -$74,124,915. On average, 4 Wall Street analysts forecast ATAI's earnings for 2026 to be -$124,710,162, with the lowest ATAI earnings forecast at -$184,310,600, and the highest ATAI earnings forecast at -$72,121,539.

In 2027, ATAI is forecast to generate -$91,153,612 in earnings, with the lowest earnings forecast at -$118,199,189 and the highest earnings forecast at -$64,108,035.

What is ATAI's revenue growth forecast for 2025-2027?

(NASDAQ: ATAI) Atai Life Sciences Nv's forecast annual revenue growth rate of 32.06% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 55.22%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.26%.

Atai Life Sciences Nv's revenue in 2025 is $1,863,000.On average, 2 Wall Street analysts forecast ATAI's revenue for 2025 to be $470,793,381, with the lowest ATAI revenue forecast at $320,540,174, and the highest ATAI revenue forecast at $621,046,588. On average, 1 Wall Street analysts forecast ATAI's revenue for 2026 to be $300,506,414, with the lowest ATAI revenue forecast at $300,506,414, and the highest ATAI revenue forecast at $300,506,414.

In 2027, ATAI is forecast to generate $1,021,721,806 in revenue, with the lowest revenue forecast at $1,021,721,806 and the highest revenue forecast at $1,021,721,806.

What is ATAI's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ATAI) forecast ROA is -34.28%, which is lower than the forecast US Biotechnology industry average of 43.47%.

What is ATAI's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ATAI price target, the average ATAI price target is $11.00, with the highest ATAI stock price forecast at $12.00 and the lowest ATAI stock price forecast at $10.00.

On average, Wall Street analysts predict that Atai Life Sciences Nv's share price could reach $11.00 by Jul 2, 2026. The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 297.11% from the current ATAI share price of $2.77.

What is ATAI's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ATAI) Atai Life Sciences Nv's current Earnings Per Share (EPS) is -$0.91. On average, analysts forecast that ATAI's EPS will be -$0.54 for 2025, with the lowest EPS forecast at -$0.72, and the highest EPS forecast at -$0.37. On average, analysts forecast that ATAI's EPS will be -$0.62 for 2026, with the lowest EPS forecast at -$0.92, and the highest EPS forecast at -$0.36. In 2027, ATAI's EPS is forecast to hit -$0.46 (min: -$0.59, max: -$0.32).

What is ATAI's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ATAI) forecast ROE is -44.14%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.